To determine whether the addition of a methylene unit in the side chain of the Asp or Arg residue in α-human atrial natriuretic peptide (α-hANP) influences its biological activity, analogs of α-hANP, [Glu13]-α-hANP (7-28) (1), [Aad13]-α-hANP (7-28) (2), and [Harn]-α-hANP(7-28) (where n is any possible combination of 11, 14 and 27) (3-9), where the original Asp or Arg residue was replaced by a homo-amino acid, were synthesized by the solid-phase synthesis method. All the analogs were evaluated for their receptor binding, cyclic guanosine monophosphate (cGMP) accumulation activity in rat vascular smooth muscle cells (VSMC), and for vasorelaxant activity employing rat aorta. 1 and 2 were 0.9 and 0.03 times as potent as α-hANP (7-28), respectively, in binding. Har-containing analogs (3-9) were as potent as α-hANP (7-28) in binding. Among the Har-containing analogs, [Har11, 14]-α-hANP (7-28) (6) and [Har11, 27]-α-hANP (7-28) (7) were remarkably vasorelaxant active, being 4.2 and 5.3 times potent than α-hANP (7-28), respectively, in spite of relatively lower cGMP accumulation activity in the case of 7. The roles of the chargeable amino acid residues in biological activity are discussed.
为了确定在 α-人心房利
钠肽(α-hANP)的 Asp 或 Arg 残基侧链中添加亚甲基单元是否会影响其
生物活性,α-hANP 的类似物 [Glu13]-α-hANP (7-28) (1)、固相合成法合成了[Aad13]-α-hANP(7-28)(2)和[Harn]-α-hANP(7-28)(其中 n 是 11、14 和 27 的任意组合)(3-9)的类似物。对所有类似物进行了受体结合、大鼠血管平滑肌细胞(VSMC)中环
磷酸鸟苷(cGMP)积累活性以及大鼠主动脉血管舒张活性的评估。1 和 2 的结合力分别是 α-hANP (7-28)的 0.9 倍和 0.03 倍。含 Har 的类似物(3-9)与 α-hANP (7-28) 的结合力相同。在含 Har 的类似物中,[Har11, 14]-α-hANP (7-28) (6)和[Har11, 27]-α-hANP (7-28) (7)具有显著的血管舒张活性,分别是 α-hANP (7-28) 的 4.2 倍和 5.3 倍,尽管 7 的 cGMP 积聚活性相对较低。